Stacked rolled newspapers with black and white text and images.

Newsroom

Meliodays’ hub for providing you with the latest press releases, news, background stories, and further press material for download.

Contact for media enquiries

Trudy Au
VP Brand Marketing & Communications
communications@meliodays.com

News & Updates

18.12.2025

Meliodays’ recent pharmacokinetic (PK) study explored the feasibility of local, sustained Celecoxib delivery via a novel intrauterine device to minimize systemic exposure while maintaining local therapeutic levels. 

18.11.2025

Meliodays won in the Health category of SüddeutscheZeitung’s GipfelSturmer Awards 2025. Meliodays has developed a non-hormonal, locally acting therapy that releases painkillers directly into the uterus to alleviate menstrual pain.

Image of CEO Simone

20.03.2025

Meliodays Medical announces the closing of a pre-seed financing round of over €800,000

Addressing a high unmet medical need in menstrual pain with microdoses of painkillers through local application

New partnership announcement between Celanese and Meliodays, featuring a visual of an intrauterine device

29.07.2025

Celanese’s VitalDose® Drug Delivery Platform will enable a long-acting, patient-centric formulation for Meliodays’ IUD design

Industry Developments

Logo for the American College of Obstetricians and Gynecologists featuring a stylized figure of a woman with a small child on her back and the text "ACOG" and "The American College of Obstetricians and Gynecologists."

13.06.2025